Full Text
PCR64 Enhancing Early-Phase Trial Outcomes: The Value of Patient-Reported Treatment Tolerability

Abstract

Authors

Elizabeth Hribal Nathan Johnson Blaise Cureg Kathy Vong

Back to Volume 28, Supplemental Issue 6S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×